Can I read COVID-19 Survival and its impact on chronic kidney disease on EtoBox?

COVID-19 Survival and its impact on chronic kidney disease by JOSHUA D. LONG; IAN STROHBEHN; RANI SAWTELL; ROBY BHATTACHARYYA; MEGHAN E. SISE is a Economics, Econometrics and Finance article available to read on EtoBox.

What is COVID-19 Survival and its impact on chronic kidney disease about?

Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience chronic sequelae following infection. The long-term impact of COVID-19 infection on kidney function is largely unknown at this point in the COVID-19 pandemic. In this review, we highlight the current understanding of the pathophysiology of COVID-19-associated kidney injury and the impact COVID-19 may have on long-term kidney function. COVID-19-induced acute kidney injury may lead to tubular injury, endothelial injury, and glomerular injury. We highlight histopathologic correlates from large kidney biopsy and autopsy series. By conducting a comprehensive review of published literature to date, we summarize the rates of recovery from COVID-19-associated-AKI. Finally, we discuss how certain genetic differences, including APOL1 risk alleles (a risk factor for collapsing glomerulopathy), coupled with systemic healthcare disparities, may lead to a disproportionate burden of post-COVID-19-kidney function decline among racial and ethnic minority groups. We highlight the need for prospective studies to determine the true incidence of chronic kidney disease burden after COVID-19.

Who reads COVID-19 Survival and its impact on chronic kidney disease?

Author

JOSHUA D. LONG; IAN STROHBEHN; RANI SAWTELL; ROBY BHATTACHARYYA; MEGHAN E. SISE

Publisher

Elsevier BV

Published

2021

Language

EN

Field

Economics, Econometrics and Finance (Physical Sciences)